Showing results (1581-1590 of 25,161) with videos related to

Sort By:
Pageof 2,517
Oncotarget|September 18, 2015
miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancerHaiyan Li, Jiao Li, Song Jia, et al.
Oncotarget|September 18, 2015
Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem?Alessandra Iurlo, Emanuela Orsi, Daniele Cattaneo, et al.
Oncotarget|September 18, 2015
Efficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: a meta-analysisTengfei Zhang, Ling Cao, Jing Xie, et al.
Oncotarget|September 18, 2015
High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancerTao Qin, Yin-duo Zeng, Ge Qin, et al.
Oncotarget|September 18, 2015
Cranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivationLaura A Kresty, Katherine M Weh, Bree Zeyzus-Johns, et al.
Oncotarget|September 18, 2015
Expression profile of innate immune receptors, NLRs and AIM2, in human colorectal cancer: correlation with cancer stages and inflammasome componentsRongrong Liu, Agnieszka D Truax, Liang Chen, et al.
Oncotarget|September 18, 2015
The NF-κB p65/miR-23a-27a-24 cluster is a target for leukemia treatmentYong-Chang Zhang, Hui Ye, Zhi Zeng, et al.
Oncotarget|September 18, 2015
Human mesenchymal stem cells enhance the systemic effects of radiotherapyVirgínea de Araújo Farias, Francisco O'Valle, Borja Alonso Lerma, et al.
Oncotarget|September 18, 2015
SIP1 is a downstream effector of GADD45G in senescence induction and growth inhibition of liver tumor cellsGuiqin Xu, Li Zhang, Aihui Ma, et al.
Oncotarget|September 18, 2015
HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancerSusmita Mondal, Debarshi Roy, Juliana Camacho-Pereira, et al.
Pageof 2,517